Kiran Philip

893 total citations
24 papers, 607 citations indexed

About

Kiran Philip is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Kiran Philip has authored 24 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Kiran Philip's work include Lipoproteins and Cardiovascular Health (7 papers), Cardiac pacing and defibrillation studies (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kiran Philip is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Cardiac pacing and defibrillation studies (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kiran Philip collaborates with scholars based in United States, Canada and Mexico. Kiran Philip's co-authors include Ernst R. Schwarz, Anita Phan, Ryan P. Morrissey, W.H. Wilson Tang, Frederick Van Lente, Stanley L. Hazen, Shirley Mann, Marie-Luise Brennan, Wilson Tong and Jesse Naghi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The American Journal of Cardiology.

In The Last Decade

Kiran Philip

24 papers receiving 590 citations

Peers

Kiran Philip
B. Hedblad Sweden
Qing Wan China
Urh Grošelj Slovenia
Jennifer Staab United States
Laura M.G. Meems Netherlands
Alan K. Matsumoto United States
B. Hedblad Sweden
Kiran Philip
Citations per year, relative to Kiran Philip Kiran Philip (= 1×) peers B. Hedblad

Countries citing papers authored by Kiran Philip

Since Specialization
Citations

This map shows the geographic impact of Kiran Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiran Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiran Philip more than expected).

Fields of papers citing papers by Kiran Philip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiran Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiran Philip. The network helps show where Kiran Philip may publish in the future.

Co-authorship network of co-authors of Kiran Philip

This figure shows the co-authorship network connecting the top 25 collaborators of Kiran Philip. A scholar is included among the top collaborators of Kiran Philip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiran Philip. Kiran Philip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Milan, Jean Bergeron, Ángel Alberto García Peña, et al.. (2023). Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study. Cardiology and Therapy. 12(4). 703–722. 5 indexed citations
3.
Reading, Stephanie, Bradley Saul, Leah J. McGrath, et al.. (2020). <p>Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines</p>. Clinical Epidemiology. Volume 12. 835–845. 2 indexed citations
4.
5.
Baum, Seth J., et al.. (2019). Geographic Variation In LDL-C Levels And Lipid Lowering Therapy Use In Patients With Atherosclerotic Cardiovascular Disease. Journal of clinical lipidology. 13(3). e32–e33. 1 indexed citations
6.
Colantonio, Lisandro D., Robert S. Rosenson, Luqin Deng, et al.. (2019). Adherence to Statin Therapy Among US Adults Between 2007 and 2014. Journal of the American Heart Association. 8(1). e010376–e010376. 105 indexed citations
7.
Colantonio, Lisandro D., Robert S. Rosenson, Luqin Deng, et al.. (2018). Abstract MP76: Trends in Adherence to Statin Therapy Among US Adults With Health Insurance Between 2007 and 2014. Circulation. 137(suppl_1). 1 indexed citations
8.
Wang, Jing, et al.. (2015). GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats. Journal of Biomedical Research. 29(3). 203–203. 97 indexed citations
9.
Philip, Kiran, et al.. (2013). Left ventricular noncompaction cardiomyopathy: updated review. Therapeutic Advances in Cardiovascular Disease. 7(5). 260–273. 56 indexed citations
10.
Morrissey, Ryan P., Jamal S. Rana, Daniel Luthringer, et al.. (2011). Case of fulminant giant-cell myocarditis associated with polymyositis, treated with a biventricular assist device and subsequent heart transplantation. Heart & Lung. 40(4). 340–345. 6 indexed citations
11.
Morrissey, Ryan P., Kiran Philip, & Ernst R. Schwarz. (2011). Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.. PubMed. 22(1). 38–44. 31 indexed citations
12.
Schwarz, Ernst R., Kiran Philip, Sinan A. Simsir, et al.. (2010). Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick. Journal of Religion and Health. 50(4). 872–879. 6 indexed citations
13.
Agarwal, Megha, et al.. (2010). Growth hormone and testosterone in heart failure therapy. Expert Opinion on Pharmacotherapy. 11(11). 1835–1844. 7 indexed citations
14.
Thompson, Keith A., Kiran Philip, & Ernst R. Schwarz. (2010). Clinical Applications of Bivalirudin in the Cardiac Catheterization Laboratory. Journal of Cardiovascular Pharmacology and Therapeutics. 16(2). 140–149. 5 indexed citations
15.
Thompson, Keith A., Parag Bharadwaj, Kiran Philip, & Ernst R. Schwarz. (2010). Heart failure therapy: beyond the guidelines. Journal of Cardiovascular Medicine. 11(12). 919–927. 5 indexed citations
16.
Naghi, Jesse, et al.. (2010). The Effects of Spirituality and Religion on Outcomes in Patients with Chronic Heart Failure. Journal of Religion and Health. 51(4). 1124–1136. 49 indexed citations
17.
Thompson, Keith A., Kiran Philip, Sinan A. Simsir, & Ernst R. Schwarz. (2010). Review: The New Concept of ‘‘Interventional Heart Failure Therapy’’: Part 2—Inotropes, Valvular Disease, Pumps, and Transplantation. Journal of Cardiovascular Pharmacology and Therapeutics. 15(3). 231–243. 6 indexed citations
18.
Phan, Anita, Waguih William IsHak, Biing‐Jiun Shen, et al.. (2010). Persistent Sexual Dysfunction Impairs Quality of Life after Cardiac Transplantation. The Journal of Sexual Medicine. 7(8). 2765–2773. 15 indexed citations
19.
Tang, W.H. Wilson, Marie-Luise Brennan, Kiran Philip, et al.. (2006). Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure. The American Journal of Cardiology. 98(6). 796–799. 142 indexed citations
20.
Tang, W.H. Wilson, Kiran Philip, Stanley L. Hazen, et al.. (2005). Comparative sensitivities betweendifferent plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure. Clinical cornerstone. 7. S18–S24. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026